Pub Date : 2023-06-01Epub Date: 2023-05-25DOI: 10.3114/fuse.2023.11.07
S C Fryar, D E A Catcheside
During a survey of freshwater fungi in temperate southern Australia, two new taxa were found, Melanascoma panespora and Pleurotheciumbrunius. Morphological and molecular data place Melanascoma panespora in the Diaporthomycetidae representing a new genus. Melanascoma, along with Proliferophorum and Paraproliferophorum, form a new lineage and the family Melanascomaceae is introduced. Phylogenetic analyses using ITS, 28S, and 18S nrRNA gene sequences,, along with morphological examination revealed Pleurothecium brunius to be a new species of Pleurothecium, sister to P. aquaticum. Citation: Fryar SC, Catcheside DEA (2023). Freshwater ascomycetes from southern Australia: Melanascomaceae fam. nov., Melanascoma panesporagen. et. sp. nov., and Pleurotheciumbruniussp. nov. Fungal Systematics and Evolution11: 85-93. doi: 10.3114/fuse.2023.11.07.
{"title":"Freshwater ascomycetes from southern Australia<i>: Melanascomaceae fam. nov., Melanascoma panespora</i><i>gen. et. sp. nov.,</i> and <i>Pleurothecium</i><i>brunius</i><i>sp. nov</i>.","authors":"S C Fryar, D E A Catcheside","doi":"10.3114/fuse.2023.11.07","DOIUrl":"10.3114/fuse.2023.11.07","url":null,"abstract":"<p><p>During a survey of freshwater fungi in temperate southern Australia, two new taxa were found, <i>Melanascoma panespora</i> and <i>Pleurothecium</i> <i>brunius</i>. Morphological and molecular data place <i>Melanascoma panespora</i> in the <i>Diaporthomycetidae</i> representing a new genus. <i>Melanascoma</i>, along with <i>Proliferophorum</i> and <i>Paraproliferophorum</i>, form a new lineage and the family <i>Melanascomaceae</i> is introduced. Phylogenetic analyses using ITS, 28S, and 18S nrRNA gene sequences,, along with morphological examination revealed <i>Pleurothecium brunius</i> to be a new species of <i>Pleurothecium</i>, sister to <i>P. aquaticum</i>. <b>Citation:</b> Fryar SC, Catcheside DEA (2023). Freshwater ascomycetes from southern Australia<i>: Melanascomaceae fam. nov., Melanascoma panespora</i> <i>gen. et. sp. nov.,</i> and <i>Pleurothecium</i> <i>brunius</i> <i>sp. nov</i>. <i>Fungal Systematics and Evolution</i> <b>11</b>: 85-93. doi: 10.3114/fuse.2023.11.07.</p>","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"21 1","pages":"85-93"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88686751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.2.3521855
J. Gavazzi
The Liver Meeting-the American Association for the Study of Liver Diseases (AASLD) 2022 annual meeting-returned to in-person attendance for the first time in 2 years since the COVID-19 public health emergency began and included a virtual option. Comprised of scientists and healthcare profession-als, AASLD is the leading organization committed to preventing and curing liver disease. The "hottest meeting in hepatology, " according to the AASLD, included plenary sessions, presenta-tions and over 4,800 scientific s highlighting the latest scientific advancements in the field of hepatology. Research and clinical trial updates were provided in many specific liver disease areas, including hepatitis, fibrosis, nonalcoholic fatty liver disease, cirrhosis, nonalcoholic steatohepatitis, trans-plantation, and so on. Along with groundbreaking research in hepatology, many presentations included the impact of COVID-19 on patients with these diseases. This report highlights a selec-tion of presentations about treatment updates provided during the conference.
{"title":"The Liver Meeting 2022 - American Association for the Study of Liver Diseases (AASLD). 73rd Annual Meeting. Washington, D.C. - November 4-8, 2022","authors":"J. Gavazzi","doi":"10.1358/dof.2023.48.2.3521855","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3521855","url":null,"abstract":"The Liver Meeting-the American Association for the Study of Liver Diseases (AASLD) 2022 annual meeting-returned to in-person attendance for the first time in 2 years since the COVID-19 public health emergency began and included a virtual option. Comprised of scientists and healthcare profession-als, AASLD is the leading organization committed to preventing and curing liver disease. The \"hottest meeting in hepatology, \" according to the AASLD, included plenary sessions, presenta-tions and over 4,800 scientific s highlighting the latest scientific advancements in the field of hepatology. Research and clinical trial updates were provided in many specific liver disease areas, including hepatitis, fibrosis, nonalcoholic fatty liver disease, cirrhosis, nonalcoholic steatohepatitis, trans-plantation, and so on. Along with groundbreaking research in hepatology, many presentations included the impact of COVID-19 on patients with these diseases. This report highlights a selec-tion of presentations about treatment updates provided during the conference.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.3.3474539
S. Vaccaro, L. Ferro Desideri, P. Bianchi, A. Vagge, R. Manocchio, V. Scorcia, C. Traverso, F. Calabria, G. Giannaccare
{"title":"Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration","authors":"S. Vaccaro, L. Ferro Desideri, P. Bianchi, A. Vagge, R. Manocchio, V. Scorcia, C. Traverso, F. Calabria, G. Giannaccare","doi":"10.1358/dof.2023.48.3.3474539","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3474539","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"34 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.1.3476558
{"title":"Imlunestrant. Selective estrogen receptor degrader (SERD), Treatment of breast cancer","authors":"","doi":"10.1358/dof.2023.48.1.3476558","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3476558","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.2.3474010
M. Cazzola, P. Rogliani, L. Calzetta, M. Matera
{"title":"Tozorakimab. Anti-IL-33 monoclonal antibody, Treatment of COPD and asthma, Treatment of atopic dermatitis, Treatment of diabetic kidney disease","authors":"M. Cazzola, P. Rogliani, L. Calzetta, M. Matera","doi":"10.1358/dof.2023.48.2.3474010","DOIUrl":"https://doi.org/10.1358/dof.2023.48.2.3474010","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.3.3567668
P. Brown, A. Merritt, S. Skerratt, M. Swarbrick
{"title":"Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022","authors":"P. Brown, A. Merritt, S. Skerratt, M. Swarbrick","doi":"10.1358/dof.2023.48.3.3567668","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3567668","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.1.3448337
{"title":"NCX-470. Nitric oxide-donating prostaglandin analogue, Treatment of glaucoma, Treatment of ocular hypertension","authors":"","doi":"10.1358/dof.2023.48.1.3448337","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3448337","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.3.3521861
T. L. Jensen, A. Brønden, K. Karstoft, D. Sonne, M. B. Christensen
{"title":"Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity","authors":"T. L. Jensen, A. Brønden, K. Karstoft, D. Sonne, M. B. Christensen","doi":"10.1358/dof.2023.48.3.3521861","DOIUrl":"https://doi.org/10.1358/dof.2023.48.3.3521861","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66447024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1358/dof.2023.48.1.3435133
{"title":"Pruxelutamide. Androgen receptor antagonist, Treatment of metastatic castration-resistant prostate cancer, Treatment of metastatic breast cancer","authors":"","doi":"10.1358/dof.2023.48.1.3435133","DOIUrl":"https://doi.org/10.1358/dof.2023.48.1.3435133","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号